Mitsuyama T, Furuno T, Hidaka K, Hara N
Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Res Exp Med (Berl). 1996;196(5):301-7. doi: 10.1007/BF02576854.
Neutrophils are thought to play a key role in tissue injury. We investigated the effect of roxithromycin, a 14-membered ring macrolide, on human neutrophil functions. The drug inhibited N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide (O2-) production and Ca2+ influx of human neutrophils. The inhibition was overcome by adding an inhibitor of cyclic AMP-dependent protein kinase (PKA), H-89. These results suggest that the drug affects O2- production and intracellular Ca2+ concentration of neutrophils via the action of PKA. Moreover, roxithromycin ameliorated endothelial cell injury induced by neutrophils, which may be, in part, due to the effect of the drug on neutrophils. Thus, roxithromycin may contribute to the treatment of diseases worsened by the excessive action of neutrophils.
中性粒细胞被认为在组织损伤中起关键作用。我们研究了14元环大环内酯类药物罗红霉素对人中性粒细胞功能的影响。该药物抑制了人中性粒细胞中N-甲酰甲硫氨酰亮氨酰苯丙氨酸(fMLP)诱导的超氧化物(O2-)生成和Ca2+内流。通过添加环磷酸腺苷依赖性蛋白激酶(PKA)抑制剂H-89可克服这种抑制作用。这些结果表明,该药物通过PKA的作用影响中性粒细胞的O2-生成和细胞内Ca2+浓度。此外,罗红霉素改善了中性粒细胞诱导的内皮细胞损伤,这可能部分归因于该药物对中性粒细胞的作用。因此,罗红霉素可能有助于治疗因中性粒细胞过度作用而恶化的疾病。